Clinical Trials Logo

Ulcerative Colitis in Remission clinical trials

View clinical trials related to Ulcerative Colitis in Remission.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05656391 Completed - Clinical trials for Ulcerative Colitis in Remission

Impact of Bread Diet on Intestinal Dysbiosis and Irritable Bowel Syndrome Symptoms in Quiescent Ulcerative Colitis

Start date: December 16, 2019
Phase: N/A
Study type: Interventional

The present study aimed to compare the in vivo prebiotic properties of bread produced by traditional breadmaking techniques with that made using a modern breadmaking method on Irritable Bowel Syndrome-like symptoms in patients with quiescent Ulcerative Colitis. The expected outcome of the differential effects was a change in the faecal microbiome composition, which may indicate changes in the mucosa-associated microbiota.

NCT ID: NCT01301976 Completed - Clinical trials for Ulcerative Colitis in Remission

Nutritional State and Intake Nutrients Assessment in Ulcerative Colitis

Start date: March 2009
Phase: N/A
Study type: Observational

The purpose of this study is to determine the reason patients are deficient in nutrients intake such as antioxidants vitamins.

NCT ID: NCT01257399 Completed - Clinical trials for Ulcerative Colitis in Remission

Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase

Start date: November 2010
Phase: Phase 3
Study type: Interventional

To demonstrate that import Mesalazine (ASACOL®) is non-inferior to the reference drug, marketed Mesalazine, regarding the primary endpoint (rate of non-emergence of bloody stool), in patients with Ulcerative Colitis in remission, treated for 48 weeks.